Video

Why Catching Cancer Early Matters

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Photo of Dr. Usman Shah
An off-the-shelf cancer vaccine is associated with durable responses and a reduced risk of relapse and death among patients with pancreatic or colorectal cancers.
Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, Kimberly Demirhan explained.
Related Content
Image of colorectal cancer
September 17th 2025

A Patient's Guide to Understanding Colorectal Cancer

Spencer Feldman
Teri Greige with medals
September 17th 2025

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Image of FDA offices
September 17th 2025

FDA Grants Designations for D3S-001 in KRAS G12C-Mutated Cancers

Ryan Scott
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
September 17th 2025

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
Picture of FDA offices
September 17th 2025

FDA Approves Dako Omnis Test to Guide Colorectal Cancer Treatment

Spencer Feldman
Image of Dr. with text.
September 17th 2025

Off-The-Shelf Vaccine Elicits Durable Responses in Pancreatic, Colorectal Cancers

Alex Biese